136 related articles for article (PubMed ID: 33521901)
1. ASO Author Reflections: The Prognostic Significance of LODDS in Medullary Thyroid Carcinoma.
Tang J; Jiang S; Zhang B; Jiang Y
Ann Surg Oncol; 2021 Aug; 28(8):4371-4372. PubMed ID: 33521901
[No Abstract] [Full Text] [Related]
2. Construction and Validation of a Nomogram Based on the Log Odds of Positive Lymph Nodes to Predict the Prognosis of Medullary Thyroid Carcinoma After Surgery.
Tang J; Jiang S; Gao L; Xi X; Zhao R; Lai X; Zhang B; Jiang Y
Ann Surg Oncol; 2021 Aug; 28(8):4360-4370. PubMed ID: 33469797
[TBL] [Abstract][Full Text] [Related]
3. ASO Author Reflections: Revisiting the Prognostic Significance of Grade in Papillary Thyroid Carcinoma.
Ho AS; Sacks WL; Zumsteg ZS
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):852-853. PubMed ID: 32864730
[No Abstract] [Full Text] [Related]
4. ASO Author Reflections: Medullary Thyroid Cancer-Establishing Treatment Paradigms in a Rapidly Evolving Therapeutic Landscape.
Papachristos AJ; Glover AR; Sidhu SB
Ann Surg Oncol; 2022 Jan; 29(1):72-73. PubMed ID: 34739638
[No Abstract] [Full Text] [Related]
5. ASO Author Reflections: Informing Patients About New Genetic Testing.
Romero Arenas MA; Grubbs EG
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):559-560. PubMed ID: 30617867
[No Abstract] [Full Text] [Related]
6. Calcitonin negative Medullary Thyroid Carcinoma: a challenging diagnosis or a medical dilemma?
Gambardella C; Offi C; Patrone R; Clarizia G; Mauriello C; Tartaglia E; Di Capua F; Di Martino S; Romano RM; Fiore L; Conzo A; Conzo G; Docimo G
BMC Endocr Disord; 2019 May; 19(Suppl 1):45. PubMed ID: 31142313
[TBL] [Abstract][Full Text] [Related]
7. Hashimoto's Thyroiditis and Medullary Carcinoma of Thyroid.
Dasgupta S; Chakrabarti S; Mandal PK; Das S
JNMA J Nepal Med Assoc; 2014; 52(194):831-3. PubMed ID: 26905714
[TBL] [Abstract][Full Text] [Related]
8. Calcitonin-negative medullary thyroid carcinoma: the 'triple-negative' phenotype.
Murphy DC; Johnson SJ; Aspinall S
Ann R Coll Surg Engl; 2020 Mar; 102(3):e63-e66. PubMed ID: 31841033
[TBL] [Abstract][Full Text] [Related]
9. Medullary thyroid carcinoma with double negative calcitonin and CEA: a case report and update of literature review.
Gambardella C; Offi C; Clarizia G; Romano RM; Cozzolino I; Montella M; Di Crescenzo RM; Mascolo M; Cangiano A; Di Martino S; Candela G; Docimo G
BMC Endocr Disord; 2019 Oct; 19(1):103. PubMed ID: 31619220
[TBL] [Abstract][Full Text] [Related]
10. [Significance of NAD (P) H: quinone oxidoreductase 1 overexpression in prognostic evaluation of thyroid medullary carcinoma].
Jin Z; Cui X; Zhang Y; Yang Y; Li L; Lin Z; Chen L
Zhonghua Bing Li Xue Za Zhi; 2015 Feb; 44(2):128-9. PubMed ID: 25916645
[No Abstract] [Full Text] [Related]
11. Medullary thyroid carcinoma of unknown primary origin with synchronous finding of papillary thyroid carcinoma.
Hellmann AR; Patel A; Śledziński M; Obołończyk Ł; Bieńkowski M; Mikaszewski B; Kaska Ł
Endokrynol Pol; 2020; 71(2):200-201. PubMed ID: 32096551
[TBL] [Abstract][Full Text] [Related]
12. Micro-medullary thyroid carcinoma: a diagnosis not to be missed.
Lacout A; Isaac S; Marcy PY
Postgrad Med J; 2015 Apr; 91(1074):236-7. PubMed ID: 25862709
[No Abstract] [Full Text] [Related]
13. Biomarkers of medullary thyroid cancer in the prediction of cure after thyroidectomy.
Nien FJ; Chang TC
J Formos Med Assoc; 2015 Sep; 114(9):793-4. PubMed ID: 23906686
[No Abstract] [Full Text] [Related]
14. Concurrent medullary and papillary carcinoma of thyroid.
Ateşpare A; Çalış AB; Çelik Ö; Yener N; Vural Ç
Kulak Burun Bogaz Ihtis Derg; 2015; 25(3):170-3. PubMed ID: 26050858
[TBL] [Abstract][Full Text] [Related]
15. Management of Medullary Thyroid Cancer.
Viola D; Elisei R
Endocrinol Metab Clin North Am; 2019 Mar; 48(1):285-301. PubMed ID: 30717909
[TBL] [Abstract][Full Text] [Related]
16. Revisiting the Significance of Prominent C Cells in the Thyroid.
Fuchs TL; Bell SE; Chou A; Gill AJ
Endocr Pathol; 2019 Jun; 30(2):113-117. PubMed ID: 30694510
[TBL] [Abstract][Full Text] [Related]
17. Static Prognostic Factors and Appropriate Surgical Designs for Patients with Medullary Thyroid Carcinoma: The Second Report from a Single-Institution Study in Japan.
Ito Y; Miyauchi A; Kihara M; Higashiiyama T; Fukushima M; Miya A
World J Surg; 2018 Dec; 42(12):3954-3966. PubMed ID: 30051240
[TBL] [Abstract][Full Text] [Related]
18. [Progression of diagnosis and treatment of medullary thyroid carcinoma].
Wang X; Li C; Huang L; Shui CY; Liu W; Cai YC; Sun RH; Zhou YQ; Jiang J; Wang W; Zeng DF
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Apr; 54(4):306-310. PubMed ID: 30991785
[No Abstract] [Full Text] [Related]
19. A 9 years boy with MEN-2B variant of medullary thyroid carcinoma.
Sattar MA; Hadi HI; Ekramuddoula FM; Hasanuzzaman SM
Mymensingh Med J; 2013 Apr; 22(2):406-9. PubMed ID: 23715371
[TBL] [Abstract][Full Text] [Related]
20. [Expression and clinical significance of Ki67 and calcitonin in medullary thyroid carcinoma].
Feng J; Wang J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Dec; 28(24):1921-4. PubMed ID: 25895305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
